Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
<h4>Background</h4>Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1150c3cd5064b668af546466fadff3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e1150c3cd5064b668af546466fadff3d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e1150c3cd5064b668af546466fadff3d2021-11-18T07:02:21ZAdjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.1932-620310.1371/journal.pone.0014149https://doaj.org/article/e1150c3cd5064b668af546466fadff3d2010-11-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21152392/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up.<h4>Methods and findings</h4>Treatment-naïve patients starting combination ART in five programmes in Côte d'Ivoire, Kenya, Malawi and South Africa were eligible. Patients whose last visit was at least nine months before the closure of the database were considered lost to follow-up. We filled missing survival times in these patients by multiple imputation, using estimates of mortality from studies that traced patients lost to follow-up. Data were analyzed using Weibull models, adjusting for age, sex, ART regimen, CD4 cell count, clinical stage and treatment programme. A total of 15,915 HIV-infected patients (median CD4 cell count 110 cells/µL, median age 35 years, 68% female) were included; 1,001 (6.3%) were known to have died and 1,285 (14.3%) were lost to follow-up in the first year of ART. Crude estimates of mortality at one year ranged from 5.7% (95% CI 4.9-6.5%) to 10.9% (9.6-12.4%) across the five programmes. Estimated mortality hazard ratios comparing patients lost to follow-up with those remaining in care ranged from 6 to 23. Adjusted estimates based on these hazard ratios ranged from 10.2% (8.9-11.6%) to 16.9% (15.0-19.1%), with relative increases in mortality ranging from 27% to 73% across programmes.<h4>Conclusions</h4>Naïve survival analysis ignoring excess mortality in patients lost to follow-up may greatly underestimate overall mortality, and bias ART programme evaluations. Adjusted mortality estimates can be obtained based on excess mortality rates in patients lost to follow-up.Martin W G BrinkhofBen D SpycherConstantin YiannoutsosRalf WeigelRobin WoodEugène MessouAndrew BoulleMatthias EggerJonathan A C SterneInternational epidemiological Database to Evaluate AIDS (IeDEA)Public Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 11, p e14149 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Martin W G Brinkhof Ben D Spycher Constantin Yiannoutsos Ralf Weigel Robin Wood Eugène Messou Andrew Boulle Matthias Egger Jonathan A C Sterne International epidemiological Database to Evaluate AIDS (IeDEA) Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
description |
<h4>Background</h4>Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up.<h4>Methods and findings</h4>Treatment-naïve patients starting combination ART in five programmes in Côte d'Ivoire, Kenya, Malawi and South Africa were eligible. Patients whose last visit was at least nine months before the closure of the database were considered lost to follow-up. We filled missing survival times in these patients by multiple imputation, using estimates of mortality from studies that traced patients lost to follow-up. Data were analyzed using Weibull models, adjusting for age, sex, ART regimen, CD4 cell count, clinical stage and treatment programme. A total of 15,915 HIV-infected patients (median CD4 cell count 110 cells/µL, median age 35 years, 68% female) were included; 1,001 (6.3%) were known to have died and 1,285 (14.3%) were lost to follow-up in the first year of ART. Crude estimates of mortality at one year ranged from 5.7% (95% CI 4.9-6.5%) to 10.9% (9.6-12.4%) across the five programmes. Estimated mortality hazard ratios comparing patients lost to follow-up with those remaining in care ranged from 6 to 23. Adjusted estimates based on these hazard ratios ranged from 10.2% (8.9-11.6%) to 16.9% (15.0-19.1%), with relative increases in mortality ranging from 27% to 73% across programmes.<h4>Conclusions</h4>Naïve survival analysis ignoring excess mortality in patients lost to follow-up may greatly underestimate overall mortality, and bias ART programme evaluations. Adjusted mortality estimates can be obtained based on excess mortality rates in patients lost to follow-up. |
format |
article |
author |
Martin W G Brinkhof Ben D Spycher Constantin Yiannoutsos Ralf Weigel Robin Wood Eugène Messou Andrew Boulle Matthias Egger Jonathan A C Sterne International epidemiological Database to Evaluate AIDS (IeDEA) |
author_facet |
Martin W G Brinkhof Ben D Spycher Constantin Yiannoutsos Ralf Weigel Robin Wood Eugène Messou Andrew Boulle Matthias Egger Jonathan A C Sterne International epidemiological Database to Evaluate AIDS (IeDEA) |
author_sort |
Martin W G Brinkhof |
title |
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
title_short |
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
title_full |
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
title_fullStr |
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
title_full_unstemmed |
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. |
title_sort |
adjusting mortality for loss to follow-up: analysis of five art programmes in sub-saharan africa. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2010 |
url |
https://doaj.org/article/e1150c3cd5064b668af546466fadff3d |
work_keys_str_mv |
AT martinwgbrinkhof adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT bendspycher adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT constantinyiannoutsos adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT ralfweigel adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT robinwood adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT eugenemessou adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT andrewboulle adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT matthiasegger adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT jonathanacsterne adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica AT internationalepidemiologicaldatabasetoevaluateaidsiedea adjustingmortalityforlosstofollowupanalysisoffiveartprogrammesinsubsaharanafrica |
_version_ |
1718424074225451008 |